This consultation closed on Tuesday, 30 March 2021.
The Therapeutic Goods Administration (TGA) sought to understand potential obstacles and incentives to repurposing of prescription medicines that may influence a sponsor's decision to extend an indication for an existing medicine. To assist in identifying potential regulatory and reimbursement policy options and further consultation may occur.
